FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289964706> ?p ?o ?g. }

• W4289964706 endingPage "185" @default.
• W4289964706 startingPage "176" @default.
• W4289964706 abstract "The aim of the study was to compare the effect of three initial doses of the anti-VEGF ranibizumab and aflibercept medication on serous pigment epithelial detachment (PED), subretinal fluid (SRF) and intraretinal fluid (IRF) in the macula of treatment naive neovascular AMD (nvAMD) patients.The cohort consists of 148 patients, of which 74 patients were treated with ranibizumab (51 females and 23 males) and 74 with aflibercept (46 females and 28 males). The data was recorded prospectively from the moment of diagnosis and start of treatment for a period of 3 months. At the moment of diagnosis and 3 months later, an OCT examination (Spectralis OCT, Heidelberg Engineering, Heidelberg, Germany) was performed. The OCT examination included a macular scan with 25 scans. Using the OCT instrument software, we measured the maximum anterior-posterior elevation of serous PED, the highest thickness of SRF and the largest diameter of the intraretinal cystic space. The statistical significance of differences between groups was evaluated using the t-test for continuous data and the Fisher exact test for categorical data. Changes in values of continuous variables over time were evaluated using the Wilcoxon paired test. Paired comparisons of binary parameters were determined by the McNemar test.Full regression of PED, SRF and IRF occurred in 3 (4.1%), 25 (39%) and 20 (51%) patients treated with ranibizumab, and in 5 (7.9%, p = 0.470), 28 (47%, p = 0.470) and 25 (57%, p = 0.827) patients treated with aflibercept, respectively. The average regression of PED, SRF and IRF was -60.4 &#956;m (median -37.5 &#956;m), -84.3 &#956;m (median -85 &#956;m) and -109.3 &#956;m (median -81 &#956;m) in patients treated with ranibizumab, and -46.3 &#956;m (median -30 &#956;m, p = 0.389), -127.7 &#956;m (median -104 &#956;m, p = 0.096) and -204.4 &#956;m (median -163 &#956;m, p = 0.005) in patients treated with aflibercept, respectively. We did not show a statistically significant difference in the regression rates of PED, SRF and IRF between the ranibizumab and aflibercept groups. (in patients with IRF after adjustment of the higher baseline IRF volumes in patients treated with aflibercept, p = 0.891).We are convinced that ranibizumab and aflibercept have the same effect on serous PED, SRF and IRF in the macula in patients with treatment naive nvAMD during the initial loading phase." @default.
• W4289964706 created "2022-08-06" @default.
• W4289964706 creator A5004615042 @default.
• W4289964706 creator A5039715822 @default.
• W4289964706 creator A5044300424 @default.
• W4289964706 creator A5044738465 @default.
• W4289964706 creator A5050611053 @default.
• W4289964706 creator A5053460175 @default.
• W4289964706 creator A5056050601 @default.
• W4289964706 creator A5071054740 @default.
• W4289964706 creator A5071866712 @default.
• W4289964706 date "2022-05-30" @default.
• W4289964706 modified "2023-10-18" @default.
• W4289964706 title "Effect of Ranibizumab and Aflibercept on Retinal Pigment Epithelial Detachment, Subretinal, and Intra-Retinal Fluid in Age-Related Macular Degeneration" @default.
• W4289964706 cites W1500728559 @default.
• W4289964706 cites W1703806167 @default.
• W4289964706 cites W1965018345 @default.
• W4289964706 cites W2004117352 @default.
• W4289964706 cites W2068742492 @default.
• W4289964706 cites W2085712747 @default.
• W4289964706 cites W2093044616 @default.
• W4289964706 cites W2124415048 @default.
• W4289964706 cites W2135936686 @default.
• W4289964706 cites W2146673937 @default.
• W4289964706 cites W2216501909 @default.
• W4289964706 cites W2346873848 @default.
• W4289964706 cites W2577052657 @default.
• W4289964706 cites W2601742736 @default.
• W4289964706 cites W2753708825 @default.
• W4289964706 cites W2767736688 @default.
• W4289964706 cites W2914285558 @default.
• W4289964706 cites W2949611183 @default.
• W4289964706 cites W4211236610 @default.
• W4289964706 cites W4233242124 @default.
• W4289964706 cites W4250031098 @default.
• W4289964706 doi "https://doi.org/10.31348/2022/20" @default.
• W4289964706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35922146" @default.
• W4289964706 hasPublicationYear "2022" @default.
• W4289964706 type Work @default.
• W4289964706 citedByCount "0" @default.
• W4289964706 crossrefType "journal-article" @default.
• W4289964706 hasAuthorship W4289964706A5004615042 @default.
• W4289964706 hasAuthorship W4289964706A5039715822 @default.
• W4289964706 hasAuthorship W4289964706A5044300424 @default.
• W4289964706 hasAuthorship W4289964706A5044738465 @default.
• W4289964706 hasAuthorship W4289964706A5050611053 @default.
• W4289964706 hasAuthorship W4289964706A5053460175 @default.
• W4289964706 hasAuthorship W4289964706A5056050601 @default.
• W4289964706 hasAuthorship W4289964706A5071054740 @default.
• W4289964706 hasAuthorship W4289964706A5071866712 @default.
• W4289964706 hasBestOaLocation W42899647061 @default.
• W4289964706 hasConcept C105795698 @default.
• W4289964706 hasConcept C118487528 @default.
• W4289964706 hasConcept C126322002 @default.
• W4289964706 hasConcept C141071460 @default.
• W4289964706 hasConcept C150173356 @default.
• W4289964706 hasConcept C186282968 @default.
• W4289964706 hasConcept C191093355 @default.
• W4289964706 hasConcept C2776403814 @default.
• W4289964706 hasConcept C2776694085 @default.
• W4289964706 hasConcept C2777802072 @default.
• W4289964706 hasConcept C2778749236 @default.
• W4289964706 hasConcept C2780827179 @default.
• W4289964706 hasConcept C2781100027 @default.
• W4289964706 hasConcept C33923547 @default.
• W4289964706 hasConcept C65409693 @default.
• W4289964706 hasConcept C71924100 @default.
• W4289964706 hasConceptScore W4289964706C105795698 @default.
• W4289964706 hasConceptScore W4289964706C118487528 @default.
• W4289964706 hasConceptScore W4289964706C126322002 @default.
• W4289964706 hasConceptScore W4289964706C141071460 @default.
• W4289964706 hasConceptScore W4289964706C150173356 @default.
• W4289964706 hasConceptScore W4289964706C186282968 @default.
• W4289964706 hasConceptScore W4289964706C191093355 @default.
• W4289964706 hasConceptScore W4289964706C2776403814 @default.
• W4289964706 hasConceptScore W4289964706C2776694085 @default.
• W4289964706 hasConceptScore W4289964706C2777802072 @default.
• W4289964706 hasConceptScore W4289964706C2778749236 @default.
• W4289964706 hasConceptScore W4289964706C2780827179 @default.
• W4289964706 hasConceptScore W4289964706C2781100027 @default.
• W4289964706 hasConceptScore W4289964706C33923547 @default.
• W4289964706 hasConceptScore W4289964706C65409693 @default.
• W4289964706 hasConceptScore W4289964706C71924100 @default.
• W4289964706 hasIssue "4" @default.
• W4289964706 hasLocation W42899647061 @default.
• W4289964706 hasLocation W42899647062 @default.
• W4289964706 hasOpenAccess W4289964706 @default.
• W4289964706 hasPrimaryLocation W42899647061 @default.
• W4289964706 hasRelatedWork W1703806167 @default.
• W4289964706 hasRelatedWork W2088240633 @default.
• W4289964706 hasRelatedWork W2235304655 @default.
• W4289964706 hasRelatedWork W2751008833 @default.
• W4289964706 hasRelatedWork W2760097671 @default.
• W4289964706 hasRelatedWork W2981677128 @default.
• W4289964706 hasRelatedWork W2989298720 @default.
• W4289964706 hasRelatedWork W4236181141 @default.
• W4289964706 hasRelatedWork W4289964706 @default.
• W4289964706 hasRelatedWork W4311284637 @default.

• next